Recent studies have also revealed that the majority of leiomyomas can be classified into three main molecular subtypes, reflecting mutations in MED12, HMGA2, and FH. Furthermore, we and others have shown that each subtype is characterized by a distinct global gene expression pattern [7,14], suggesting that leiomyomas could be classified by gene expression profiling. The gene discussed is FH; the disease is leiomyoma.